Valuation : Cegedim

Market Cap 14Cr 16Cr 13Cr 12Cr 23Cr 1.57TCr 23Cr 157.02Cr 61Cr 790.3Cr 62Cr 60Cr 2.62TCr P/E 2026 *
6.74x
P/E 2027 * 5.14x
Enterprise Value 30Cr 35Cr 28Cr 26Cr 49Cr 3.36TCr 49Cr 337.39Cr 131.64Cr 1.7TCr 132.15Cr 129.28Cr 5.63TCr EV / Sales 2026 *
0.46x
EV / Sales 2027 * 0.4x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 week-1.15%
Current month-0.39%
1 month+0.98%
3 months-11.76%
6 months-3.93%
Current year-24.41%
1 week 10.16
Extreme 10.16
10.4
1 month 10.1
Extreme 10.1
10.62
3 years 8.66
Extreme 8.66
20.7
5 years 8.66
Extreme 8.66
29.3
Manager TitleAgeSince
Chief Executive Officer 83 25/10/2009
Director of Finance/CFO - 14/06/2016
Corporate Officer/Principal 55 26/11/2015
Director TitleAgeSince
Chairman 83 25/10/2009
Director/Board Member 72 09/08/2010
Director/Board Member 55 26/10/2009
Change 5-day change 1-year change 3-year change Capi.($)
-0.39%-0.58%-4.37%-50.10% 16Cr
-0.72%+2.99%-33.29%+25.03% 43TCr
+0.76%+1.70%-17.43%+48.54% 26TCr
+4.54%+12.63%-21.14%+24.99% 15TCr
-7.34%+6.76%-61.93%+233.69% 4.89TCr
+1.23%+4.02%-30.48%+14.93% 4.83TCr
-0.30%-1.63%-24.19%+29.86% 2.49TCr
-0.06%-4.07%-22.06%+62.36% 2.03TCr
+2.37%+8.81%-5.15%+151.04% 1.71TCr
-0.86%+1.26%-24.51%+12.48% 1.42TCr
Average -0.04%+5.54%-24.45%+55.28% 11.27TCr
Weighted average by Cap. +0.28%+4.91%-27.69%+43.35%

Financials

2026 *2027 *
Net sales 66Cr 77Cr 62Cr 56Cr 106.34Cr 7.32TCr 106.68Cr 733.67Cr 286.25Cr 3.69TCr 287.37Cr 281.12Cr 12TCr 68Cr 79Cr 64Cr 59Cr 110.29Cr 7.59TCr 110.65Cr 760.93Cr 296.89Cr 3.83TCr 298.05Cr 291.56Cr 13TCr
Net income 2.13Cr 2.47Cr 2Cr 1.82Cr 3.43Cr 236.25Cr 3.45Cr 24Cr 9.24Cr 119.26Cr 9.28Cr 9.08Cr 395.43Cr 2.8Cr 3.25Cr 2.63Cr 2.4Cr 4.51Cr 310.56Cr 4.53Cr 31Cr 12Cr 156.77Cr 12Cr 12Cr 519.81Cr
Net Debt 16Cr 19Cr 15Cr 14Cr 26Cr 1.8TCr 26Cr 180.37Cr 70Cr 907.85Cr 71Cr 69Cr 3.01TCr 13Cr 16Cr 13Cr 11Cr 22Cr 1.48TCr 22Cr 148.78Cr 58Cr 748.84Cr 58Cr 57Cr 2.48TCr
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
-
Date Price Change
28/26/28 €10.28 -0.39%
27/26/27 €10.32 -0.19%
26/26/26 €10.34 +0.98%
25/26/25 €10.24 +0.79%
24/26/24 €10.16 -2.31%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
10.28EUR
Average target price
15.50EUR
Spread / Average Target
+50.78%

Quarterly revenue - Rate of surprise